EMCDDA Scientific Committee

The task of the Scientific Committee is to assist the Management Board and the Director of the EMCDDA by delivering an opinion on any scientific matter concerning the Centre's activity which the Management Board or the Director may submit to it. In addition, the risk assessment of new psychoactive substances is carried out by the Scientific Committee, in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended by regulation (EU) 2017/2101).

About

The EMCDDA Scientific Committee is set up by Article 13 of Regulation (EC) No 1920/2006 of the European Parliament and of the Council on the European Monitoring Centre for Drugs and Drug Addiction (as amended by regulation (EU) 2017/2101).

The Committee consists of fifteen well-known scientists appointed by the Management Board in view of their scientific excellence and their independence, following a publication of a call for expressions of interest in the Official Journal of the European Union. The selection procedure ensures that the specialist fields of the members of the Scientific Committee cover the most relevant scientific fields linked to the problems of drug and drug addiction. The members of the Scientific Committee are appointed in a personal capacity and give their opinions completely independently of the Member States and the Community Institutions and serve for a three-year period (renewable).

The Scientific Committee is requested by the EMCDDA founding regulation to give a formal opinion on the EMCDDA programming documents on the basis of a draft submitted by the Centre's Director before it is presented to the Management Board. The Scientific Committee reviews many of the EMCDDA publications with regard to their scientific quality, plays an important role in the risk assessment of new psychoactive substances and supports the different working areas of the EMCDDA. Since its constitution, the Scientific Committee has established itself as an important pillar of the EMCDDA’s institutional life, ensuring the scientific legitimacy of the Centre and providing for continuous improvement of the main outputs.

Minutes from recent Scientific Committee meetings and other reference documents are available under Documents.

Rules of procedure of the EMCDDA Scientific Committee.

Documents

1
2
3
4
5
next ›

Members

Scientific field	Member		Affiliation	Nationality	Specific expertise	Documents
Basic biological, neurobiological and behavioural research	Dr. Fernando Rodríguez de Fonseca	Member	Fundación IMABIS, Málaga, Spain	Spanish	Biochemistry, Pharmacology, Neurobiology of drug addiction, Basic research	001_Declaration of interest_template for members SC_200129-nosign.pdf001_Declaration of independence_template for members SC_200129-nosign.pdfFernando Rodriguez de Fonseca cv.pdf
Demand reduction	Dr. Marta Torrens Mèlich	Member	Universitat Autonoma de Barcelona, Hospital del Mar Medical Research Institute and Neuropsychiatry and Addictions Institute, Consorci Parc de Salut Mar, Barcelona, Spain	Spanish	Psychiatry	MTorrens-Declaration of interest-nosign.pdfMTorrens-Declaration of Independence-members SC-nosign.pdfMarta Torrens cv.pdf
Demand reduction	Prof. Dr. Gabriele Fischer	Member	Center of Public Health, Department of Psychiatry & Psychotherapy, Medical University Vienna, Austria	Austrian	Psychiatry, Neuroscience, Addiction research, Teaching, Policy and treatment, Public health, Gender research in psychiatry, Human rights	EMCDDA_Declaration of Interest-nosign.pdfEMCDDA_Declaration of Independence-nosign.pdfGabriele Fischer cv.pdf
Demand reduction	Prof. Dr. Thomas Clausen	Member	Norwegian Centre for Addiction Research (SERAF), Institute of Clinical Medicine, University of Oslo, Norway	Norwegian	Addiction Research, Prevention of health consequences of drug use, Drug related mortality	Declaration-of-interest-Thomas-ClaussenDeclaration-of-independence-Thomas-ClaussenShort-CV-Thomas-Clausen
Demand reduction	Dr. Laura Ferrer-Wreder	Member	Department of Psychology, Stockholm University	Swedish	Addiction Research, Hidden populations, Clinical psychology	Declaration-of-interest-Laura-Ferrer-WrederDeclaration-of-independence-Laura-Ferrer-WrederShort-CV-Laura-Ferrer-Wreder
Drug policy	Prof. Dr. Henri Bergeron	Vice-Chair	Centre de Sociologie des Organisations, Sciences Po Paris, Fondation Nationale des Sciences Politiques, Paris, France	French	Sociology, Political science and policy evaluation	Declaration of interest Henri Bergeron.pdfDeclaration of independence Henri Bergeron.pdfHenri Bergeron cv.pdf
Drug policy	Dr. Marie Jauffret-Roustide	Member	Inserm (French Institute of Health and Medical Research), Paris, France	French	Sociology, Drug policy, Public health, Ethnicity, Gender issues, Harm reduction, Migration	Declaration-of-interest-Marie-Jauffret-Roustide001_Declaration of independenceMarieJauffretRoustide-nosign.pdfMarie Jauffret-Roustide cv.pdf
Population-based research and epidemiology	Prof. Dr. Catherine Comiskey	Chair	School of Nursing and Midwifery, Trinity College Dublin, The University of Dublin	Irish	Epidemiology, Mathematics, Modelling of treatment outcomes, Incidence and prevalence, Translation of research into policy and practice, Healthcare statistics	Declaration-of-interest-Catherine-Comiskey.pdfDeclaration-of-independence-Catherine-Comiskey.pdfShort-CV-Catherine-Comiskey.pdf
Population-based research and epidemiology	Prof. Dr. Ilkka Ojanperä	Member	Department of Forensic Medicine, University of Helsinki and Forensic Toxicology Unit, Finnish Institute for Health and Welfare, Helsinki, Finland	Finnish	Pharmacology & Toxicology	Declaration of interest Ojanperä0001-nosign.pdfDeclaration of independence Ojanperä0001-nosign.pdfShort CV Ojanperä.pdf
Population-based research and epidemiology	Prof. Dr. Margarida Gaspar de Matos	Member	Faculdade de Motricidade Humana and Instituto de Saúde Ambiental/Faculdade de Medicina, University of Lisbon, Portugal	Portuguese	Epidemiology, Incidence and prevalence	Declaration of interest-nosign.pdfEMCDDA_MGM_DeclofIndependence_2020-nosign.pdfMargarida Gaspar de Matos cv.pdf
Population-based research and epidemiology	Dr. Tomi Lintonen	Member	Finnish Foundation for Alcohol Studies, Helsinki, Finland	Finnish	Health promotion, Epidemiology, Public health	001_Declaration_of_interest_Lintonen.pdf001_Declaration_of_independence_Lintonen.pdf001_ShortCV_Lintonen.pdf
Population-based research and epidemiology	Dr. Jo-Hanna Ivers	Member	School of Medicine, Trinity College Dublin	Irish	Epidemiology, Public health and addiction epidemiology, Addiction research	Declaration-of-interest-Jo-Hanna-IversDeclaration-of-independence-Jo-Hanna-IversShort-CV-Jo-Hanna-Ivers.pdf
Supply, supply reduction and crime	Dr. Kim Moeller	Member	Faculty of Health and Society, Department of criminology, Malmö University, Sweden	Danish	Criminology, Drug trafficking	Moeller_001_Declaration of interest_template for members SC_200129-nosign.pdfMoeller_001_Declaration of independence_template for members SC_200129-nosign.pdfMoeller_001_ShortCV.pdf
Supply, supply reduction and crime	Prof. Dr. Marieke Liem	Member	Institute of Security and Global Affairs, Leiden University, The Netherlands	Dutch	Criminology, Clinical psychology	001_Declaration of interest_template for members SC_200129 ML-nosign.pdf001_Declaration of independence_template for members SC_200129 ML-nosign.pdfMarieke Liem cv.pdf
Supply, supply reduction and crime	Dr. Charlotte Colman	Member	Professor Drug Policy and Criminology (Department of Criminology, Criminal Law & Social Law, Ghent University)	Belgian	Drug policy, Crime prevention, Criminology, Policy and treatment	Declaration-of-interest-Charlotte-ColmanDeclaration-of-independence-Charlotte-ColmanShort-CV-Charlotte-Colman.pdf

EMCDDA Scientific Committee

On this page

About

Documents

Members

On this page

Keyword(s)